Sunbury Heights were appointed to manage the design and construction of the new Moscow headquarters of Novartis Pharma (adding to our portfolio of pharmaceutical clients which already includes GlaxoSmithKline, Merck, Schering, Schering Plough and IVAX). Responsible also for full cost control on the project, Sunbury Heights was chosen for this 2800m2 project against stiff international competition.